Combined renin-angiotensin system gene polymorphisms and outcomes in coronary artery disease - A preliminary report

Kardiologia Polska

Volumn 69, Issue 7, 2011, Pages 688-695

  Dzielińska, Zofia ^a   Małek, Łukasz A ^a   Roszczynko, Marta ^a   Szperl, Małgorzata ^a   Demkow, Marcin ^a   Ka̧dziela, Jacek ^a   Prejbisz, Aleksander ^a   Zieliński, Tomasz ^a   Januszewicz, Andrzej ^a   Ruzyłło, Witold ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Coronary artery disease; Outcomes; Polymorphisms; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ALLELE; ARTICLE; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STROKE; TREATMENT OUTCOME;

EID: 79960695081     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Lusis AJ, Fogelman AM, Fonarow GC. Genetic basis of atherosclerosis, part II: clinical implications. Circulation, 2004; 110: 2066-2071. (Pubitemid 39331923)
2. Rechciński T, Grȩbowska A, Kurpesa M et al. Interleukin-1b and interleukin-1 receptor inhibitor gene cluster polymorphisms in patients with coronary artery disease after percutaneous angioplasty or coronary artery bypass grafting. Kardiol Pol, 2009; 67: 601-610.
3. Szperl M, Dzielinska Z, Roszczynko M et al. Genetic variants in hypertensive patients with coronary artery disease and coexisting atheromatous renal artery stenosis. Med Sci Monit, 2008; 14: CR611-CR616.
4. Samani NJ, Thompson JR, O'Toole L, Channer K, Woods KL. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation, 1996; 94: 708-712. (Pubitemid 26289226)
5. Ntzani EE, Rizos EC, Ioannidis JP. Genetic effects versus bias for candidate polymorphisms in myocardial infarction: case study and overview of large-scale evidence. Am J Epidemiol, 2007; 165: 973-984. (Pubitemid 46598826)
6. Neri Serneri GG, Boddi M, Modesti PA et al. Cardiac angiotensin II participates in coronary microvessel inflammation of unstable angina and strengthens the immunomediated component. Circ Res, 2004; 94: 1630-1637. (Pubitemid 38856971)
7. Luft FC. Cardiac angiotensin is upregulated in the hearts of unstable angina patients. Circ Res, 2004; 94: 1530-1532. (Pubitemid 38856959)
8. Jaffe IZ, Mendelsohn ME. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells. Circ Res, 2005; 96: 643-650. (Pubitemid 40478331)
9. Kretowski A, McFann K, Hokanson JE et al. Polymorphisms of the renin-angiotensin system genes predict progression of subclinical coronary atherosclerosis. Diabetes, 2007; 56: 863-871. (Pubitemid 46348466)
10. Tiret L, Bonnardeaux A, Poirier O et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet, 1994; 344: 910-913. (Pubitemid 24295876)
11. Ludwig EH, Borecki IB, Ellison RC et al. Associations between candidate loci angiotensin-converting enzyme and angiotensinogen with coronary heart disease and myocardial infarction: the NHLBI family heart study. Ann Epidemiol, 1997; 7: 3-12. (Pubitemid 27082038)
12. Alvarez R, Reguero JR, Batalla A et al. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms: association with early coronary disease. Cardiovasc Res, 1998; 40: 375-379. (Pubitemid 28506048)
13. Fatini C, Abbate R, Pepe G et al. Searching for a better assessment of the individual coronary risk profile: the role of angiotensin-converting enzyme, angiotensin II type 1 receptor and angiotensinogen gene polymorphisms. Eur Heart J, 2000; 21: 633-638. (Pubitemid 30168814)
14. Fomicheva EV, Gukova SP, Larionova-Vasina VI, Kovalev YR, Schwartz EI. Gene-gene interaction in the RAS system in the predisposition to myocardial infarction in elder population of St. Petersburg (Russia). Mol Genet Metab, 2000; 69: 76-80. (Pubitemid 30097307)
15. Petrovic D, Zorc M, Kanic V, Peterlin B. Interaction between gene polymorphisms of renin-angiotensin system and metabolic risk factors in premature myocardial infarction. Angiology, 2001; 52: 247-252. (Pubitemid 32332571)
16. Araujo MA, Goulart LR, Cordeiro ER et al. Genotypic interactions of renin-angiotensin system genes in myocardial infarction. Int J Cardiol, 2005; 103: 27-32. (Pubitemid 41074600)
17. Tsai CT, Hwang JJ, Ritchie MD et al. Renin-angiotensin system gene polymorphisms and coronary artery disease in a large angiographic cohort: detection of high order gene-gene interaction. Atherosclerosis, 2007; 195: 172-180. (Pubitemid 47561934)
18. Gilanowska G, Domal-Kwiatkowska D, Smolik S et al. Familial hypertrophic cardiomyopathy: insertion-deletion polymorphism of angiotensin-converting enzyme and angiotensin II receptor. Kardiol Pol, 2005; 62: 449-450.
19. Lizanecz E, Pasztor ET, Mohacsi A, Papp Z, Edes I, Toth A. Mistyping of angiotensinogen M235T alleles. Hypertens Res, 2006; 29: 197-201.
20. van Geel PP, Pinto YM, Zwinderman AH, et al. Increased risk for ischaemic events is related to combined RAS polymorphism. Heart, 2001; 85: 458-462. (Pubitemid 32973539)
21. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest, 1990; 86: 1343-1346. (Pubitemid 20370444)
22. Jeunemaitre X, Ledru F, Battaglia S et al. Genetic polymorphisms of the renin-angiotensin system and angiographic extent and severity of coronary artery disease: the CORGENE study. Hum Genet, 1997; 99: 66-73. (Pubitemid 26419858)
23. Schunkert H, Hense H, Gimenez-Roqueplo A et al. The angiotensinogen T235 variant and the use of antihypertensive drugs in a population-based cohort. Hypertension, 1997; 29: 628-633. (Pubitemid 27074729)
24. Thekkumkara TJ, Thomas WG, Motel TJ, Baker KM. Functional role for the angiotensin II receptor (AT1A) 3′-untranslated region in determining cellular responses to agonist: evidence for recognition by RNA binding proteins. Biochem J, 1998; 329 (Part 2): 255-264.
25. Thekkumkara TJ, Linas SL. Evidence for involvement of 3′-untranslated region in determining angiotensin II receptor coupling specificity to G-protein. Biochem J, 2003; 370 (Part 2): 631-639. (Pubitemid 36315151)
26. Sethupathy P, Borel C, Gagnebin M, et al. Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3′ untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet, 2007; 81: 405-413. (Pubitemid 47236088)
27. Schelleman H, Klungel OH, Witteman JC et al. Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers. Eur J Hum Genet, 2007; 15: 478-484. (Pubitemid 46487703)
28. Sata Y, Krum H. The future of pharmacological therapy for heart failure. Circ J, 2010; 74: 809-817.
29. Schwartz GL, Turner ST. Pharmacogenetics of antihypertensive drug responses. Am J Pharmacogenomics, 2004; 4: 151-160. (Pubitemid 38879783)
30. Arnett DK, Davis BR, Ford CE et al. Pharmacogenetic association of the angiotensin-converting enzyme Insertion/Deletion polymorphism on blood pressure and cardiovascular risk in relation to antihypertensive treatment: the genetics of hypertension-associated treatment (GenHAT) study. Circulation, 2005; 111: 3374-3383. (Pubitemid 40923390)
31. Tsikouris JP, Peeters MJ. Pharmacogenomics of renin angiotensin system inhibitors in coronary artery disease. Cardiovasc Drugs Ther, 2007; 21: 121-132. (Pubitemid 46834913)
32. Brugts JJ, Isaacs A, Boersma E et al. Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary disease. Eur Heart J, 2010; 31: 1854-1864.
33. Gardemann A, Stricker J, Humme J et al. Angiotensinogen T174M and M235T gene polymorphisms are associated with the extent of coronary atherosclerosis. Atherosclerosis, 1999; 145: 309-314. (Pubitemid 29359139)